Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: Risk factors for Alzheimer's dementia?

Neuroscience Letters

Volumn 274, Issue 1, 1999, Pages 37-40

  Thome, J ^a   Gewirtz, J C ^a   Sakai, N ^a   Zachariou, V ^a   Retz Junginger, P ^b   Retz, W ^b   Duman, R S ^a   Rosler M ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Alzheimer's dementia; Apolipoprotein; Bleomycin hydrolase; Genetics; Polymorphism; Risk factor

Indexed keywords

APOLIPOPROTEIN E; HYDROLASE;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CYSTEINE ENDOPEPTIDASES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 0032885851     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00662-X     Document Type: Article

References (23)

1. Ahmed A.R., MacGowan S.H., Culpan D., Jones R.W., Wilcock G.K. The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoE epsilon4 allele and Alzheimer's disease. Neurosci. Lett. 263:1999;217-219.
2. Artiga M.J., Bullido M.J., Frank A., Sastre I., Recuero M., Garcia M.A., Lendon C.L., Han S.W., Morris J.C., Vazquez J., Goate A., Valdivieso F. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum. Mol. Genet. 7:1998;1887-1892.
3. Brömme D., Rossi A.B., Smeekens S.P., Anderson D.C., Payan D.G. Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization. Biochemistry. 35:1996;6706-6714.
4. Bullido M.J., Artiga M.J., Recuero M., Sastre I., García M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vázquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet. 18:1998;69-71.
5. Farrer L.A., Abraham C.R., Haines J.L., Rogaeva E.A., Song Y., McGraw W.T., Brindle N., Premkumar S., Scott W.K., Yamaoka L.H., Saunders A.M., Roses A.D., Auerbach S.A., Sorbi S., Duara R., Pericak-Vance M.A., St. George-Hyslop P.H. Association between bleomycin hydrolase and Alzheimer's disease in Caucasians. Ann. Neurol. 44:1998;808-811.
6. Forsell Y., Corder E.H., Basun H., Lannfelt L., Viitanen M., Winblad B. Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+. Biol. Psychiatry. 42:1997;898-903.
7. Kamboh M.I., Aston C.E., Perez-Tur J., Kokmen E., Ferrell R.E., Hardy J., DeKosky S.T. A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease. Neurosci. Lett. 263:1999;129-132.
8. Lambert J.C., Berr C., Pasquier F., Delacourte A., Frigard B., Cottel D., Perez-Tur J., Mouroux V., Mohr M., Cecyre D., Galasko D., Lendon C., Poirier J., Hardy J., Mann D., Amouyel P., Chartier-Harlin M.C. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum. Mol. Genet. 7:1998;1511-1516.
9. Laws S.M., Taddei K., Martins G., Paton A., Fisher C., Clarnette R., Hallmayer J., Brooks W.S., Gandy S.E., Martins R.N. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. NeuroReport. 10:1999;879-882.
10. Montoya S.E., Aston C.E., DeKosky S.T., Kamboh M.I., Lazo J.S., Ferrell R.E. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's dementia. Nat. Genet. 18:1998;211-212.
11. Montoya S.E., Ferrell R.E., Lazo J.S. Genomic structure and genetic mapping of the human neutral cysteine protease bleomycin hydrolase. Cancer Res. 57:1997;4191-4195.
12. Paik Y.-K., Chang D.J., Reardon C.A., Davies G.E., Mahley R.W., Taylor J.M. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc. Natl. Acad. Sci. USA. 82:1985;3445-3449.
13. Papassotiropoulos A., Bagli M., Jessen F., Bayer T.A., Maier W., Rao M.L., Heun R. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann. Neurol. 45:1999;666-668.
14. Reynolds W.F., Rhees J., Maciejewski D., Paladino T., Sieburg H., Maki R.A., Masliah E. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol. 155:1999;31-41.
15. Rocha L., Garcia C., de Mendonca A., Gil J.P., Bishop D.T., Lechner M.C. N-Acetyltransferase (NAT2) genotype and susceptibility of sporadic Alzheimer's disease. Pharmacogenetics. 9:1999;9-15.
16. Roks G., Cruts M., Bullido M.J., Backhovens H., Artiga M.J., Hofman A., Valdivieso F., Van Broeckhoven C., Van Duijn C.M. The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease. Neurosci. Lett. 258:1998;65-68.
17. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
18. Song Y.Q., Rogaeva E., Premkumar S., Brindle N., Kawarai T., Orlacchio A., Yu G., Levesque G., Nishimura M., Ikeda M., Pei Y., O'Toole C., Duara R., Baker W., Sorbi S., Freedman M., Farrer L., St. George-Hyslop P. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE. Neurosci. Lett. 250:1998;189-192.
19. Steffens D.C., Plassman B.L., Helms M.J., Welsh-Bohmer K.A., Saunders A.M., Breitner J.C. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol. Psychiatry. 41:1997;851-856.
20. Toji H., Maruyama H., Sasaki K., Nakamura S., Kawakami H. Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population. Neurosci. Lett. 259:1999;56-58.
21. Town T., Paris D., Fallin D., Duara R., Barker W., Gold M., Crawford F., Mullan M. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Neurosci. Lett. 252:1998;95-98.
22. Wetherell J.L., Gatz M., Johansson B., Pedersen N.L. History of depression and other psychiatric illness as risk factors for Alzheimer disease in a twin sample. Alzheimer Dis. Assoc. Disord. 13:1999;47-52.
23. Yasuda M., Hirono N., Maeda K., Imamura T., Mori E., Tanaka C. Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 66:1999;722-726.